A safer vaccine for Alzheimer's disease? (Q35019424)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470795 AND SRC:MED&resulttype=core&format=json

15 December 2019

review article

1 reference

title

A safer vaccine for Alzheimer's disease? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470795 AND SRC:MED&resulttype=core&format=json

15 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470795 AND SRC:MED&resulttype=core&format=json

15 December 2019

Thomas Wisniewski

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470795 AND SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Blas Frangione

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470795 AND SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470795 AND SRC:MED&resulttype=core&format=json

15 December 2019

published in

Neurobiology of Aging

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470795 AND SRC:MED&resulttype=core&format=json

15 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470795 AND SRC:MED&resulttype=core&format=json

15 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470795 AND SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

1001-1008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470795 AND SRC:MED&resulttype=core&format=json

Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Alzheimer's Disease from the Perspective of the Systemic and Localized Forms of Amyloidosis

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Reduced levels of amyloid beta-peptide antibody in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

High affinity binding of monoclonal antibodies to the sequential epitope EFRH of beta-amyloid peptide is essential for modulation of fibrillar aggregation

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

N-terminal EFRH sequence of Alzheimer's β-amyloid peptide represents the epitope of its anti-aggregating antibodies

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Human antibodies reactive with beta-amyloid protein in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Piecing together Alzheimer's.

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Antibody-mediated resolution of light chain-associated amyloid deposits.

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Autoantibodies to amyloid-beta and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Alzheimer disease therapeutics

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Amyloid beta40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice.

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Prion (PrPSc)-specific epitope defined by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Passage of human amyloid beta-protein 1-40 across the murine blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity.

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Permeability and Residual Plasma Volume of Human, Dutch Variant, and Rat Amyloid β-Protein 1-40 at the Blood–Brain Barrier

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Local and distant histopathological effects of unilateral amyloid-beta 25-35 injections into the amygdala of young F344 rats

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

In vivo reversal of amyloid-beta lesions in rat brain.

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Neuroautoimmunity: pathogenic implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Disaggregation of Alzheimer beta-amyloid by site-directed mAb.

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Cerebrospinal fluid proteins: III. Normal values of immunoglobulins G, A and M (variations related to race, sex and age)

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

The mouse C1q A-chain sequence alters beta-amyloid-induced complement activation

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Fact and speculation on the function of immune response genes in antigen presentation

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Biology of Aβ Amyloid in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Increased incidence of anti-beta-amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Can Blood–Brain Barrier Play a Role in the Development of Cerebral Amyloidosis and Alzheimer's Disease Pathology

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

Blood-brain barrier transport of circulating Alzheimer's amyloid beta

1 reference

https://api.crossref.org/works/10.1016/S0197-4580(02)00124-0

7 January 2021

10.1016/S0197-4580(02)00124-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12470795 AND SRC:MED&resulttype=core&format=json

15 December 2019

1 reference